Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stoke Therapeutics (STOK) Net Income: 2022-2024

Historic Net Income for Stoke Therapeutics (STOK) over the last 3 years, with Dec 2024 value amounting to -$88.7 million.

  • Stoke Therapeutics' Net Income fell 45.09% to -$38.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.4 million, marking a year-over-year increase of 138.26%. This contributed to the annual value of -$88.7 million for FY2024, which is 15.38% up from last year.
  • According to the latest figures from FY2024, Stoke Therapeutics' Net Income is -$88.7 million, which was up 15.38% from -$104.9 million recorded in FY2023.
  • Over the past 5 years, Stoke Therapeutics' Net Income peaked at -$88.7 million during FY2024, and registered a low of -$104.9 million during FY2023.
  • For the 3-year period, Stoke Therapeutics' Net Income averaged around -$98.3 million, with its median value being -$101.2 million (2022).
  • In the last 5 years, Stoke Therapeutics' Net Income decreased by 3.59% in 2023 and then increased by 15.38% in 2024.
  • Stoke Therapeutics' Net Income (Yearly) stood at -$101.2 million in 2022, then fell by 3.59% to -$104.9 million in 2023, then grew by 15.38% to -$88.7 million in 2024.